RxDoctor Payments Data

Wayne Brandes, DO

Family Medicine · Melbourne, FLNPI 1174962807

Payments from drug & device makers

$291in general payments, 2019–2025

Across 18 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$63
  • Amarin Pharma, Inc.$61
  • Novo Nordisk$37
  • Pfizer$30
  • Astellas Pharma US Inc$30
  • Hologic Sales And Service, LLC$22
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$291100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$291 in reported general payments places this provider in the 40th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$83,838
Medicare patients
399
Services billed
3,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AtivanLorazepam11$86,625
EliquisApixaban45$67,646
OzempicSemaglutide45$59,282
JardianceEmpagliflozin26$26,205
RybelsusSemaglutide14$18,681
Tresiba Flextouch U-100Insulin Degludec16$10,822
MyrbetriqMirabegron11$7,018
Atorvastatin Calcium326$5,348
Lisinopril421$4,791
Levothyroxine Sodium287$4,754
Rosuvastatin Calcium158$3,924
SynthroidLevothyroxine Sodium31$3,618
Tamsulosin Hcl162$3,444
Doxepin Hcl20$3,258
Omeprazole159$3,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$37$77,96359 claims
PfizerEliquis$30$67,64645 claims
Astellas Pharma US IncMyrbetriq$30$7,01811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →